DLAT and cholangiocarcinoma: Figure 1D demonstrates that DLAT expression was upmodulated in 7 distinct cancer types: cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), stomach adenocarcinoma (STAD), and stomach and esophageal carcinoma (STES).